# Amitriptyline in Treating Hypoglycemia

> **NCT03591458** · PHASE2 · TERMINATED · sponsor: **University of Utah** · enrollment: 2 (actual)

## Conditions studied

- Type1 Diabetes Mellitus
- Hypoglycemia Unawareness

## Interventions

- **DRUG:** Amitriptyline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03591458
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-08-01
- **Primary completion:** 2019-06-03
- **Final completion:** 2019-06-03
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Slow subject enrollment, unable to complete trial in a timely manner
- **Last updated:** 2019-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03591458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03591458, "Amitriptyline in Treating Hypoglycemia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03591458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*